Best lymphangioma oncologists: TOP 88 doctors

She received her medical education in Russia. After completing her residency in Berlin, Dr. Steingraeber worked as a specialist and senior physician at the Charité, the Neukölln Hospital in Berlin and in the practice of radiooncology. Dr. Steingraeber speaks fluent Russian. Her clinical specialization includes bronchial carcinoma and breast carcinoma.

Membership/Committee Service:

DEGRO, ARO, DKG, AGSMO

Member of interdisciplinary committees for the development of guidelines:

Esophageal carcinoma

Anal carcinoma

Oropharyngeal/hypopharyngeal carcinoma

Supportive therapy in oncology

Prof. Dr. med. Volker Budach *Prof. Dr.med. Volker Budach

He completed his medical studies at the University of Essen and was appointed to the Department of Radiotherapy at the Charité Hospital in Berlin in 1993. He successfully headed this department until 2022, with almost 40 years of professional and 30 years of managerial experience. Under the direction of Prof. Dr. Budach, numerous clinical studies were conducted, especially in the therapy of head and neck tumors. Along with other tumors such as sarcomas, bronchial carcinomas and breast carcinomas, which are his clinical and scientific focus. Prof. Dr. Budach founded and for many years jointly directed the comprehensive cancer center at the Charité. In addition to his function as director of the clinic, he also headed the Charité Center 14, which combined the topics of imaging and oncology. Prof. Budach was President of the German Society for Radiation Oncology (DEGRO) and President of its congress. At the EORTC, he headed the head and neck tumour group for many years. He is the author of numerous important papers on the optimisation of radiotherapy and chemotherapy in the treatment of head and neck tumours. After 30 years of leading the clinic, Prof. Dr. Budach decided to transfer his experience in radiation oncology to the RadioOnkologie Vosspalais clinic. Prof. Dr. Budach is a member of the professional associations DEGRO, ESTRO, ASTRO.

She completed her training at the Charité in Berlin and has been a specialist in radiotherapy for 20 years. She worked as a senior physician in all departments of the Charité in Berlin, and from 2007 to 2015 she was a senior physician and deputy director of the Charité clinic in Berlin. In 2015, she was appointed head of the department of radiotherapy at the University Hospital of Cologne and very successfully headed the clinic there until 2022. Since the end of 2022, she has been heading the private radiotherapy clinic "RadioOnkologie Vosspalais". Clinical areas include radioimmunotherapy, high-precision therapy, multimodal therapy of gynecological tumors and prostate carcinoma.

Professor Dr. Marnitz is a member of the German and European Guidelines for the Therapy of Endometrial Carcinoma. She is also an independent external expert of the European Council for the Therapy of Carcinoma of the Cervical, Vulvar and Vaginal Cancer. Professor Dr. Marnitz is a member of the German and European Guidelines for the Therapy of Endometrial Carcinoma. She is also an independent external expert of the European Council for the Therapy of Carcinoma of the Cervical, Vulvar and Vaginal Cancer. Several randomized clinical trials have been conducted under her leadership.

Professor Dr. Marnitz is an honorary member of the Russian Society of Gynecological Oncology, a member of the professional societies DEGRO, ESTRO, ASTRO. In 2024, Professor Dr. Marnitz will be the president of the congress of the annual conference of the German Society of Radiation Oncology.

Dr. Ilker Nihat Okten is a board-certified medical oncologist. He is accredited by the European Society of Medical Oncology (ESMO). Dr. Okten has worked as a sub-investigator in several phase III clinical trials. His work has helped advance cancer treatment. He specializes in chemotherapy, immunotherapy, targeted therapy, hormonal therapy, and palliative care.

He is a member of ESMO, ASCO, and the Turkish Society of Medical Oncology. Dr. Okten has published several articles in oncology. He is active in both research and clinical practice.

Dr. Raj Nagarkar is a leading Surgical Oncologist with 19 years of experience. He has performed over 50,000 cancer surgeries. His main focus areas are Breast and Thoracic Surgical Oncology. He is involved in more than 200 clinical trials and has contributed to many national and international publications.

Dr. Nagarkar trained in Surgical Oncology at Tata Memorial Hospital, Mumbai. He also holds an MRCS from the Royal College of Surgeons, Edinburgh. He teaches DNB Superspecialty Surgical Oncology and Breast Surgery at Maharashtra University of Health Sciences. Dr. Nagarkar is dedicated to improving the quality of life for his patients.

AREAS OF INTEREST

• Breast cancer
• Colon cancer
• Lung cancer
• Malignant melanoma
• Urogenital cancers
• Gynecological cancers
• Digestive sy cancers

Education and Specialization

• 1987-1993 BSc Faculty of Medicine, Uludağ University Faculty of Medicine
• 1994-1999 BSc Internal Medicine Ondokuz Mayıs University Faculty of Medicine
• 2008-2011 PhD Medical Oncology Ankara Numune Training and Research Hospital
• 2016 Assoc. Prof. / Prof. Dr. Medical Oncology Okmeydanı Training and Research Hospital

Experience

• 1993-1994 General Practitioner Senirkent State Hospital Senirkent, Isparta
• 1994-1999 Research Position Ondokuz Mayıs University Faculty of Medicine Internal Medicine Department, Samsun
• 2000-2006 Specialist Doctor Diyarbakır SSK Hospital, Diyarbakır
• 2006-2008 Specialist Doctor Diyarbakır State Hospital, Diyarbakır
• 2008-2011 Dr. Minor Assistant Ankara Numune Training and Research Hospital
• 2011-2013 Specialist Doctor Diyarbakır Training and Research Hospital, Medical Oncology
• 2013- 2016 Specialist Doctor Okmeydanı Training and Research Hospital, Medical Oncology Clinic
• 2016 Education Manager Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Assoc. Prof.

Professional Memberships

Turkish Society of Medical Oncology

Education and Training:

• Medical Degree: Graduated from Uludağ University Faculty of Medicine in 1993.
• Specialization in Internal Medicine: Completed at Ondokuz Mayıs University Faculty of Medicine in 1999.
• Medical Oncology Fellowship: Completed at Ankara Numune Research and Training Hospital in 2011.
•  
• Professional Experience:
• Isparta Senirkent State Hospital: Completed his mandatory service as an Internal Medicine Specialist and Hemodialysis Responsible Physician (1993-1994).
• Prof. Dr. Gazi Yaşargil Training and Research Hospital: Served as a Medical Oncologist (2011-2013).
• Okmeydanı Research and Training Hospital: Achieved the title of Associate Professor and later full Professor, significantly contributing to medical oncology (2013-2016).
• Current Position: Professor of Medical Oncology at İstinye University Hospital Medical Park Gaziosmanpaşa, Istanbul, where he continues to provide top-tier oncology care and mentorship.

Areas of Expertise:

• Cancer Treatment: Specializes in the treatment of various cancers, including breast, colon, lung, malignant melanoma, urogenital, gynecological, and gastrointestinal cancers.
• Advanced Therapies: Proficient in administering chemotherapy, immunotherapy, and other cutting-edge treatments for cancer patients.
• Research and Education: Actively involved in cancer research and dedicated to educating the next generation of oncologists, continuously enhancing the field through both clinical practice and academic contributions.

• Extensive Experience:
•  
• With over 24 years of medical practice, Prof. Dr. Cihan is a highly respected figure in oncology, known for his comprehensive approach to cancer treatment.
• International Recognition: Participates in numerous international seminars and congresses, keeping abreast of the latest advancements in oncology.
• Patient-Centric Care: Renowned for his compassionate and personalized approach to patient care, ensuring tailored treatment plans that address the unique needs of each patient.
• Multidisciplinary Collaboration: Works with a multidisciplinary team of experts at Medical Park, providing holistic and coordinated care to achieve the best possible outcomes for patients.

Achievements and Awards:

• Academic Contributions: Has contributed significantly to oncology literature and research, with numerous publications in reputable medical journals.
• Leadership in Oncology: Recognized for his leadership in oncology, both in clinical settings and academic institutions, influencing cancer treatment practices and policies.

Oncologist-mammologist

Treatment of mastopathy, which causes pain and swelling of the mammary gland

Treatment of large breast cysts without surgical aspiration

Treatment of duct ectasia (dilation) and galactorrhea

Obtaining a smear from the secretion of the mammary gland

Treatment of adenosis and other precancerous diseases of the mammary gland

Biopsy of pathological formations on the skin of the mammary gland

Hormonal treatment for breast cancer

Treatment of precancerous diseases of other organs

Cancer Treatment

Symptomatic treatment of cancer patients

Mistletoe therapy and cancer treatment with high doses of vitamin C.

Elimination of complications and side effects of chemotherapy and radiation therapy

Pain Treatment for Cancer Patients (Natural Pain Relief and Life Extension)

Participant of many conferences and seminars with the participation of German doctors in Azerbaijan, as well as in Germany and Turkey.

Dr. Sridhar P.S. is a skilled radiation oncologist. He earned his Bachelor of Medicine from Mysore University. He completed his MD in Radiotherapy at Banaras Hindu University. He also holds a Diplomate of the National Board in Radiotherapy. This shows his advanced training and dedication to quality care.

Dr. Sridhar is a member of several professional groups. These include the Association of Radiation Oncology of India, Society for Neuro-Oncology, Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology. He is known for his effective cancer treatments and focus on new therapies. His work has made a positive impact in the field of oncology.

Dr. Chaitainya Borde is a nuclear medicine specialist with 12 years of clinical experience. He is skilled in advanced nuclear scans, PET-CT imaging, and nuclear cardiology. He works in both diagnostic and therapeutic nuclear medicine.

Dr. Borde has performed over 30,000 PET scans. He has managed more than 1,000 thyroid cancer patients. He is experienced in radioiodine and Lu-177 RN therapies. He has also published research papers in respected medical journals, showing his dedication to academic work.

Dr. Shruti Kate is an experienced oncologist. She specializes in treating lung, breast, gynecological, and genitourinary cancers. She earned her MBBS from Lady Hardinge Medical College. She completed her MD in Internal Medicine at Maulana Azad Medical College. She also holds a DM in Medical Oncology from Tata Memorial Hospital, Mumbai.

Dr. Kate has managed both conservative and surgical cancer treatments. She is skilled in complex procedures such as the Whipple surgery. She is a member of several leading oncology societies, including ASCO, ESMO, IASCLC, ISMPO, and IOS. Her research on lung cancer received the only travel award from India at the 2018 World Conference on Lung Cancer.

Associate Professor Dr. Emrah Eraslan graduated from Ankara University Faculty of Medicine in 2005. From 2006 to 2011, he worked as a research assistant in the Department of Internal Medicine at Ankara University Faculty of Medicine and became an internal medicine specialist in 2011. Between 2011 and 2013, he worked as an internal medicine specialist and chief physician at Dr. Nafiz Körez Sincan State Hospital and Palu District State Hospital. From 2013 to 2016, he received medical oncology training at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital and worked there until 2021. In 2023, he became an associate professor and contributed to his field with his publications throughout his career. He currently serves his patients at Koru Ankara Hospital. His medical interests include:

Breast Cancer

Prostate Cancer

Lung Cancer

Colorectal Cancer

Stomach Cancer

Ovarian Cancer

Dr. López-Ibor is a specialist in Pediatric Hematology and Oncology. She earned her medical degree from the Complutense University of Madrid and her doctorate from the University of Barcelona. She is also accredited by the University of Maryland. Dr. López-Ibor treats bone and brain tumors, leukemia, and blood disorders.

She has over 20 years of experience. Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital. She has written many scientific articles, both nationally and internationally, and has made important contributions to her field.